Moore Kari Lyn
SEC CIK 1788641 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NVST | Envista Holdings Corp | VP, Chief Acct. Off | 21.7K | — | — | 3 | 2021-11-25 | 2022-02-25 |
Most active insiders at NVST, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Reis Mischa | SVP, Strategy, Bus. Dev | — | $510.2K |
| 2 | Acurio Veronica | Pres, Orthodontics | — | — |
| 3 | Nilsson Stefan | Pres, Nobel Biocare | — | — |
| 4 | Befidi Robert | Pres, Diagnostics | — | — |
| 5 | Kaabi Faez C | CAO | — | — |
| 6 | Pierce James Andrew | Dir | — | — |
| 7 | Nance Mark E | GC | — | — |
| 8 | Keel Paul A | CEO, Dir | — | — |
| 9 | Hammes Eric D. | CFO | — | — |
| 10 | Carruthers Wendy | Dir | — | — |
Moore Kari Lyn made no open-market trades at NVST in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-01 | 2022-02-25 | NVST | Envista Holdings Corp | Moore Kari Lyn | VP, Chief Acct. Off | F - Tax | $48.52 | -1,083 | 21.7K | -5% | -$52.5K |
| D | 2022-03-01 | 2022-02-25 | NVST | Envista Holdings Corp | Moore Kari Lyn | VP, Chief Acct. Off | A - Grant | $0.00 | +3,610 | 25.3K | +17% | $0 |
| 2021-11-29 | 2021-11-25 | NVST | Envista Holdings Corp | Moore Kari Lyn | VP, Chief Acct. Off | F - Tax | $41.58 | -1,814 | 22.8K | -7% | -$75.4K |
Purchase Sale Sale after option exercise All abbreviations